Does the sphingosine 1-phosphate receptor-1 provide a better or worse prognostic outcome for breast cancer patients?

Pyne, Nigel J. and Pyne, Susan (2018) Does the sphingosine 1-phosphate receptor-1 provide a better or worse prognostic outcome for breast cancer patients? Frontiers in Oncology, 8 (417). pp. 1-3. ISSN 2234-943X (https://doi.org/10.3389/fonc.2018.00417)

Preview

Text. Filename: Pyne_Pyne_FiO2018_Does_the_sphingosine_1_phosphate_receptor_1_provide_a_better.pdf Final Published Version License: Download (101kB)| Preview

Abstract

Recently, Lei et al., (2018) published an article in Cancer Medicine claiming a survival benefit of sphingosine 1-phosphate (S1P) and sphingosine 1-phosphate receptor 1 (S1P1) expression in breast cancer patients. This controversial study opposes the prevailing view concerning the deleterious role of S1P in cancer. This is discussed in depth in the current opinion article.

• Share and Export
  

  RDF+XMLBibTeXRIOXX2 XMLRDF+N-TriplesJSONDublin CoreAtomSimple MetadataReferMETSHTML CitationASCII CitationOpenURL ContextObjectEndNoteOpenURL ContextObject in SpanMODSMPEG-21 DIDLEP3 XMLData Cite XMLRIS (EndNote Online, Zotero, Ref manager, etc)RDF+N3Multiline CSV
• Item metadata

  Item type:	Article
  ID code:	65555
  Dates:	Date Event 27 September 2018 Published 10 September 2018 Accepted
  Subjects:	Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer)
  Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
  Depositing user:	Pure Administrator
  Date deposited:	27 Sep 2018 13:18
  Last modified:	18 Apr 2024 00:23
  Related URLs:	Journal or Publication
  URI:	https://strathprints.strath.ac.uk/id/eprint/65555